A p60 polypeptide in the feline leukemia virus pseudotype of Moloney sarcoma virus with murine leukemia virus p30 antigenic determinants (original) (raw)

Abstract

A 60,000-dalton polypeptide (p60) has been identified in the feline leukemia virus (FeLV) pseudotype of Moloney sarcoma virus [MSV(FeLV)]. This polypeptide is present in the purified virus complex in concentrations greater than either the murine p30 or the feline p27. Purified p60 crossreacts immunologically with murine p30 group antiserum and contains several interspecies determinants, whereas the group specific determinant of FeLV p27 is not detected. Comparison of peptide fingerprints of p60 and murine p30 show many peptides in common. Limited digestion of p60 with either trypsin or chymotrypsin produced p30-35 and p20 peptides which retain the MuLV p30 group and interspecies antigenic activities. The p30 produced by both enzymes comigrates in polyacrylamide gels with the murine p30 of MSV(FeLV), thus suggesting that p60 may be an uncleaved precursor to p30.

2380

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aaronson S. A., Bassin R. H., Weaver C. Comparison of murine sarcoma viruses in nonproducer and S + L - -transformed cells. J Virol. 1972 Apr;9(4):701–704. doi: 10.1128/jvi.9.4.701-704.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Al-Adhami R., Chapman A. L. Aberrant viruses in cells infected with murine sarcoma virus-feline leukemia virus. J Natl Cancer Inst. 1975 Mar;54(3):763–766. [PubMed] [Google Scholar]
  3. Benveniste R. E., Scolnick E. M. RNA in mammalian sarcoma virus transformed nonproducer cells homologous to murine leukemia virus RNA. Virology. 1973 Feb;51(2):370–382. doi: 10.1016/0042-6822(73)90436-4. [DOI] [PubMed] [Google Scholar]
  4. Bolin R. W., Cummings D. J. Structural aberrations in T-even bacteriophage. V. Effects of canavanine on the maturation and utilization of specific gene products. J Virol. 1974 Jun;13(6):1378–1391. doi: 10.1128/jvi.13.6.1378-1391.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Fischinger P. J., Blevins C. S., Nomura S. Simple, quantitative assay for both xenotropic murine leukemia and ecotropic feline leukemia viruses. J Virol. 1974 Jul;14(1):177–179. doi: 10.1128/jvi.14.1.177-179.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Fischinger P. J., Peebles P. T., Nomura S., Haapala D. K. Isolation of RD-114-like oncornavirus from a cat cell line. J Virol. 1973 Jun;11(6):978–985. doi: 10.1128/jvi.11.6.978-985.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Fischinger P. J., Schaefer W., Seifert E. Detection of some murine leukemia virus antigens in virus particles derived from 3T3 cells transformed only by murine sarcoma virus. Virology. 1972 Jan;47(1):229–235. doi: 10.1016/0042-6822(72)90254-1. [DOI] [PubMed] [Google Scholar]
  8. Green R. W., Bolognesi D. P. Isolation of proteins by gel filtration in 6M guanidinium chloride: application to RNA tumor viruses. Anal Biochem. 1974 Jan;57(1):108–117. doi: 10.1016/0003-2697(74)90057-8. [DOI] [PubMed] [Google Scholar]
  9. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  10. Naso R. B., Arcement L. J., Arlinghaus R. B. Biosynthesis of Rauscher leukemia viral proteins. Cell. 1975 Jan;4(1):31–36. doi: 10.1016/0092-8674(75)90130-0. [DOI] [PubMed] [Google Scholar]
  11. Nomura S., Fischinger P. J., Mattern C. F., Peebles P. T., Bassin R. H., Friedman G. P. Revertants of mouse cells transformed by murine sarcoma virus. I. Characterization of flat and transformed sublines without a rescuable murine sarcoma virus. Virology. 1972 Oct;50(1):51–64. doi: 10.1016/0042-6822(72)90345-5. [DOI] [PubMed] [Google Scholar]
  12. Oroszlan S., Fisher C. L., Stanley T. B., Gilden R. V. Proteins of the murine C-type RNA tumour viruses: isolation of a group-specific antigen by isoelectric focusing. J Gen Virol. 1970 Jul;8(1):1–10. doi: 10.1099/0022-1317-8-1-1. [DOI] [PubMed] [Google Scholar]
  13. Oroszlan S., Summers M. R., Foreman C., Gilden R. V. Murine type-C virus group-specific antigens: interstrain immunochemical, biophysical, and amino acid sequence differences. J Virol. 1974 Dec;14(6):1559–1574. doi: 10.1128/jvi.14.6.1559-1574.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Peebles P. T., Fischinger P. J., Bassin R. H., Papageorge A. G. Isolation of human amnion cells transformed by rescuable murine sarcoma virus. Nat New Biol. 1973 Mar 28;242(117):98–101. doi: 10.1038/newbio242098a0. [DOI] [PubMed] [Google Scholar]
  15. Randerath K. An evaluation of film detection methods for weak beta-emitters, particularly tritium. Anal Biochem. 1970 Mar;34:188–205. doi: 10.1016/0003-2697(70)90100-4. [DOI] [PubMed] [Google Scholar]
  16. Rickard C. G., Post J. E., Noronha F., Barr L. M. A transmissible virus-induced lymphocytic leukemia of the cat. J Natl Cancer Inst. 1969 Jun;42(6):987–1014. [PubMed] [Google Scholar]
  17. Schafer W., Hunsmann G., Moennig V., Noranha F., Bolognesi D. P., Green R. W., Hüper G. Polypeptides of mammalian oncornaviruses. II Characterization of murine leukemia virus polypeptide (p 15) bearing interspecies reactivity. Virology. 1975 Jan;63(1):48–59. doi: 10.1016/0042-6822(75)90369-4. [DOI] [PubMed] [Google Scholar]
  18. Schäfer W., Fischinger P. J., Lange J., Pister L. Properties of mouse leukemia viruses. I. Characterization of various antisera and serological identification of viral components. Virology. 1972 Jan;47(1):197–209. doi: 10.1016/0042-6822(72)90252-8. [DOI] [PubMed] [Google Scholar]
  19. Scolnick E. M., Rands E., Williams D., Parks W. P. Studies on the nucleic acid sequences of Kirsten sarcoma virus: a model for formation of a mammalian RNA-containing sarcoma virus. J Virol. 1973 Sep;12(3):458–463. doi: 10.1128/jvi.12.3.458-463.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Strand M., August J. T. Structural proteins of mammalian oncogenic RNA viruses: multiple antigenic determinants of the major internal protein and envelope glycoprotein. J Virol. 1974 Jan;13(1):171–180. doi: 10.1128/jvi.13.1.171-180.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Todaro G. J., Aaronson S. A. Properties of clonal lines of murine sarcoma virus transformed Balb-3T3 cells. Virology. 1969 May;38(1):174–179. doi: 10.1016/0042-6822(69)90140-8. [DOI] [PubMed] [Google Scholar]
  22. Toplin I., Sottong P. Large-volume purification of tumor viruses by use of zonal centrifuges. Appl Microbiol. 1972 May;23(5):1010–1014. doi: 10.1128/am.23.5.1010-1014.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Vande Woude G. F., Bachrach H. L. Number and molecular weights of foot-and-mouth disease virus capsid proteins and the effects of maleylation. J Virol. 1971 Feb;7(2):250–259. doi: 10.1128/jvi.7.2.250-259.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Vogt V. M., Eisenman R. Identification of a large polypeptide precursor of avian oncornavirus proteins. Proc Natl Acad Sci U S A. 1973 Jun;70(6):1734–1738. doi: 10.1073/pnas.70.6.1734. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Wright B. S., O'Brien P. A., Shibley G. P., Mayyasi S. A., Lasfargues J. C. Infection of an established mouse bone marrow cell line (JLS-V9) with Rauscher and Moloney murine leukemia viruses. Cancer Res. 1967 Sep;27(9):1672–1677. [PubMed] [Google Scholar]